No Data
No Data
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/15)
[Good news] ---- ---- ■ITbook Holdings [Tokyo Stock Exchange G] Current financial results increased 26% to the highest profit for 4 consecutive terms, to 6 yen this fiscal year. ■GNI Group [TSE G] landed in surplus at the end of the January-March period (1Q). Also, we will proceed with preparations for applying for a market classification change to the Tokyo Stock Exchange Prime Market. In addition, a joint venture for drug discovery and investment businesses utilizing AI technology will be established with Oltz and Governance Partners. ■Huh
PHOENIXBIO: Notice regarding financial results of unlisted parent companies, etc.
PHOENIXBIO: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
PhoenixBio Sees FY Net Y201.00M
PhoenixBio Co. Ltd. also released the following forecasts: GROUP 1st Half To Year Ending Sep 2024 Mar 2025 Revenue Y972.00 mln Y2.12 bln Op
PhoenixBio 9-Mos Net Y14.00M Vs Net Y393.00M
PhoenixBio Co. Ltd. (6190.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y1.33 bln Y1.66 bln Operating Profit Y30.00 ml
PhoenixBio Sees FY Net Y24.00M
PhoenixBio Sees FY Net Y24.00M
No Data